ZURICH (Reuters) - Swiss drugmaker-for-hire Lonza (LONN.S) is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution. https://www.reuters.com/article/us-lonza-gene-therapy-idUSKBN1HH18I